Sclerosis multiplex (SM): vizsgálatok itt: Kína
28 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Beijing, Changchun, Chongqing, Guangzhou, Hangzhou, Hohhot, Shanghai, Shenyang, Suzhou, Taiyuan, Tianjin, Wenzhou, Wuhan, Xianyang, Yinchuan, Zhengzhou, Zunyi
- Életkor
- 18 év to 65 év
- People
- 1275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - 3. fázisTaking peopleNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Where
- Beijing, Chengdu, Dongguan, Guangzhou, Jiazhuang, Shenyang
- Életkor
- 18 év to 60 év
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00 - 2. fázisTaking peopleA Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Chuan Qin
See details and how to joinNCT07827716 - Korai 1. fázisNot yet taking people in KínaA Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 12
- Run by
- Daishi Tian
See details and how to joinNCT07748637 - 2. fázisTaking peopleA Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- Guangzhou Lupeng Pharmaceutical Company LTD.
See details and how to joinNCT07776743 - 1/2. fázisNot yet taking people in KínaPhase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 25
- Run by
- Tongji Hospital
See details and how to joinNCT07756268 - 1. fázisTaking peopleSafety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 9
- Run by
- Xijing Hospital
See details and how to joinNCT07587125 - No phaseTaking peopleBiomarkers in Autoimmune Disease of Nervous System
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 50 000
- Run by
- Tongji Hospital
See details and how to joinNCT06502015 - 1. fázisNot yet taking people in KínaA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Qingdao
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07676266 - No phaseTaking peopleCohort Study on Neuroimmune Diseases in the Reproductive Age
- Where
- Guangzhou
- Életkor
- 20 év to 55 év
- People
- 100
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT07653984 - No phaseTaking peopleClinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
- Where
- Beijing
- Életkor
- 16 év to 75 év
- People
- 1000
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT04106830 - Korai 1. fázisTaking peopleThis is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
- Where
- Hubei
- Életkor
- 18 év and over
- People
- 9
- Run by
- Daishi Tian
See details and how to joinNCT07303790 - No phaseNot yet taking people in KínaA Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07593911 - Korai 1. fázisTaking peopleCD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT07337785 - 1. fázisTaking peopleSafety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Tongji Hospital
See details and how to joinNCT07526493 - 1. fázisNot yet taking people in KínaA Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 24
- Run by
- Daishi Tian
See details and how to joinNCT07523100 - Korai 1. fázisNot yet taking people in KínaUniversal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 15
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT07392528 - No phaseNot yet taking people in KínaTongji NADs Cohort
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 1550
- Run by
- Tongji Hospital
See details and how to joinNCT07333196 - No phaseTaking peopleExploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 80
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT07353216 - No phaseCsak meghívásosNormal Chinese Lifespan Brain Charts Initiative (NCLBCI)
- Where
- Beijing
- Életkor
- 6 év to 90 év
- People
- 10 000
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT06643858 - Korai 1. fázisTaking peopleUniversal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT06939166 - No phaseTaking peopleAssessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
- Where
- Beijing
- Életkor
- 18 év to 60 év
- People
- 128
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT07087873 - 1. fázisTaking peopleA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- RenJi Hospital
See details and how to joinNCT06249438 - No phaseTaking peopleEffectiveness of Personalized Alternating Current Stimulation for Treating Cognitive Impairment in CNS Demyelination Patients
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 85
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06968039 - Korai 1. fázisNot yet taking people in KínaUniversal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06485232